Jason Aryeh serves as Executive at LIGAND PHARMACEUTICALS INC, where they oversee executive responsibilities. Since joining the company, Jason Aryeh has executed 260 insider transactions totaling $44.1M, demonstrating a bearish approach to their equity position. Their most recent transaction on Nov 16, 2009 involved selling 2,500 shares valued at $11.5K.
Jason Aryeh currently holds 71,323 shares of LIGAND PHARMACEUTICALS INC (LGND), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jason Aryeh has been a net seller of LGND stock. They have purchased $5.5M and sold $38.5M worth of shares.
Jason Aryeh's most recent insider trade was on Nov 16, 2009, when they sold 2,500 shares at $4.61 per share.
Get notified when new Form 4 filings are submitted
| $4.62 |
| Discretionary |
| Nov 16, 2009 | NABI | $1.4K | Sale | 300 | $4.63 | Discretionary |
| Nov 16, 2009 | NABI | $315.0K | Sale | 70,147 | $4.49 | Discretionary |
| Sep 15, 2009 | NABI | $0 | Will Acquisition | 17,000 | $N/A | Discretionary |
| May 29, 2009 | LGND | $0 | Award | 5,000 | $N/A | Discretionary |
| May 29, 2008 | LGND | $0 | Award | 5,000 | $N/A | Discretionary |
| May 31, 2007 | LGND | $0 | Award | 5,000 | $N/A | Discretionary |
| May 30, 2007 | LGND | $21.7K | Purchase | 3,350 | $6.48 | Discretionary |
| May 30, 2007 | LGND | $32.4K | Purchase | 5,000 | $6.48 | Discretionary |